Jason Izard

1.2k citations
46 papers · 881 · 1 hit paper · h-index 19

Impact in

  • Urology top 5%
    • Urinary Bladder and Prostate Research
  • Surgery top 10%
    • Bladder and Urothelial Cancer Treatments

Papers in

    • Prostate Cancer Treatment and Research 8
    • Prostate Cancer Diagnosis and Treatment 8
    • Bladder and Urothelial Cancer Treatments 10
    • Adrenal and Paraganglionic Tumors 3

Jason Izard

46 papers receiving 864 citations

Jason Izard's Hit Papers

Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial 2025 · 18 citations
180Years since publication51015

Peers

Jason Izard
Comparison fields: 5 of 78
  • Urology 86
  • Surgery 266
  • Oncology 136
  • Cancer Research 76
  • General Health Professions 118
Replace Christer Groeben with:
Christer Groeben Germany
Weranja K. B. Ranasinghe Australia
Corina J. G. van den Hurk Netherlands
Pranav Sharma United States
Jose Manuel Cozar-Olmo Spain
Patrick O. Richard Canada
Gary W. Chien United States
Liam Connor Macleod United States
Karin Plass Netherlands
Kyle A. Richards United States
Jason Izard relative to Christer Groeben Germany Christer Groeben's profile →
Citations per field
00.5×5×10×13.7×
Christer Groeben · 1×
Citations per year

Countries citing papers authored by Jason Izard

Since Specialization
Citations

This map shows the geographic impact of Jason Izard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Izard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Izard more than expected).

Fields of papers citing papers by Jason Izard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Izard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Izard. The network helps show where Jason Izard may publish in the future.

Co-authors

The 25 scholars most cited alongside Jason Izard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jason Izard Line = papers co-authored together Jason Izard links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.

#Work
1 201974
2 201257
3 201556
4 201053
5 201550
6 201545
7 201342
8 201338
9 201336
10 201427
11 201727
12 202026
13 201524
14 201624
15 201423
16
Parameters affecting urologic complications after major joint replacement surgery.
200622
17 201822
18 202321
19 201419
20
Durvalumab in combination with BCG for BCG-naive, high-risk, non-muscle-invasive bladder cancer (POTOMAC): final analysis of a randomised, open-label, phase 3 trial
Hit paper breakdown →
202518

About Jason Izard

Jason Izard is a scholar working on Pulmonary and Respiratory Medicine, Surgery, Oncology, Urology and General Health Professions, having authored 46 papers that have together received 881 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (10 papers), Cancer survivorship and care (9 papers), Prostate Cancer Treatment and Research (8 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Urinary Bladder and Prostate Research (4 papers), Hormonal and reproductive studies (4 papers), Adrenal and Paraganglionic Tumors (3 papers) and Health Literacy and Information Accessibility (3 papers). The work is most often cited by research in Urology (86 citations), Surgery (266 citations), Oncology (136 citations), Cancer Research (76 citations) and General Health Professions (118 citations). Jason Izard has collaborated with scholars based in Canada, United States and Bangladesh. Frequent co-authors include David Robert Siemens, John L. Gore, J. Curtis Nickel, Andrea L. Hartzler, Jonathan Lawrence Wright, Bruce L. Dalkin, Harriet E. Feilotter, Michael Leveridge, Dean A. Tripp and Gagan Fervaha. Their work appears in journals such as The Journal of Urology, Clinical Genitourinary Cancer, Canadian Urological Association Journal, Urologic Oncology Seminars and Original Investigations and British Journal of Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact